Athersys to Participate in The American Society for Neural Therapy and Repair Annual Conference
CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announced today their participation in The American Society for Neural Therapy and Repair Annual Conference from April 27-30, 2023 in Clearwater, FL. The American Society for Neural Therapy and Repair is a society of basic and clinical … [Read more…]
